Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the REVOLT study
Titel:
Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the REVOLT study
Auteur:
Rosati, Gerardo Corsi, Domenico Avallone, Antonio Brugnatelli, Silvia Dell'Aquila, Emanuela Cinausero, Marika Aprile, Giuseppe Cicero, Giuseppe Carlomagno, Chiara Colombo, Alfredo Rapisardi, Stefania Pinto, Carmine Reggiardo, Giorgio Bilancia, Domenico